2 ms·
Quite an insight to switch from cancer therapy to COVID-19 vaccine Actually not at all. BioNTech's entire platform was customized RNA therapeutics that target
by refurb 6y ago
Quite an insight to switch from cancer therapy to COVID-19 vaccine
Actually not at all. BioNTech's entire platform was customized RNA therapeutics that target the immune system to a particular patient's tumor. Basically cancer vaccines.